← Back to Search

Other

NOP-1A for Alcoholism

Phase < 1
Waitlist Available
Research Sponsored by Rajesh Narendran
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial is comparing how well a new imaging agent binds in the brains of people with and without alcohol use disorders.

Eligible Conditions
  • Alcoholism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
[C-11]NOP-1A VT

Trial Design

2Treatment groups
Experimental Treatment
Group I: ControlsExperimental Treatment2 Interventions
[C-11]NOP-1A PET Scan
Group II: Alcohol use disordersExperimental Treatment2 Interventions
[C-11]NOP-1A PET Scan
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
[C-11]
2016
Completed Early Phase 1
~150
NOP-1A
2016
Completed Early Phase 1
~110

Find a Location

Who is running the clinical trial?

Rajesh NarendranLead Sponsor
3 Previous Clinical Trials
121 Total Patients Enrolled
1 Trials studying Alcoholism
11 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
799 Previous Clinical Trials
1,362,457 Total Patients Enrolled
422 Trials studying Alcoholism
985,154 Patients Enrolled for Alcoholism

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025